Clinical Evaluation of a (1,3)-β-D-Glucan Assay for Presumptive Diagnosis of Pneumocystis jiroveci Pneumonia in Immunocompromised Patients

• author:admin
• date:2015-04-21
• click:

(1,3)-β-D-Glucan (BG) is a component of the Pneumocystis jirovecicell wall. Thirty-one immunocompromised patients with pneumonia (16 with presumptive pneumocystis pneumonia [PCP] and 15 with non-PCP) were evaluated for serum BG levels. Serum from all 16 presumptive PCP patients and from 2/15 patients with non-PCP was positive for BG. Results indicate that BG is a reliable marker for diagnosing PCP.

 

The related results are shown as follows:

 

 

The original paper is adopted from CLINICAL ANDVACCINEIMMUNOLOGY, Oct. 2009, p. 1524–1526